Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Dow
Moodys
McKinsey
Merck

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for PSN-375,963


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug PSN-375,963?

PSN-375,963 is an investigational drug.

There have been 7 clinical trials for PSN-375,963. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2020.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Neurotoxicity Syndromes, and Leukemia, Myeloid. The leading clinical trial sponsors are Sanofi, Western University, Canada, and Asklepieion Voulas General Hospital.

There are seventeen US patents protecting this investigational drug and one hundred and seventy-six international patents.

Recent Clinical Trials for PSN-375,963
TitleSponsorPhase
Topical Vancomycin Over Sternal Edge in Cardiac SurgeryNational Cheng-Kung University HospitalPhase 4
Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot StudyUniversity of AlbertaN/A
Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot StudyUniversity of TorontoN/A

See all PSN-375,963 clinical trials

Clinical Trial Summary for PSN-375,963

Top disease conditions for PSN-375,963
Top clinical trial sponsors for PSN-375,963

See all PSN-375,963 clinical trials

US Patents for PSN-375,963

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
PSN-375,963 ⤷  Try it Free Modulators of sphingosine phosphate receptors The Scripps Research Institute (La Jolla, CA) ⤷  Try it Free
PSN-375,963 ⤷  Try it Free Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level Arena Pharmaceuticals, Inc. (San Diego, CA) ⤷  Try it Free
PSN-375,963 ⤷  Try it Free Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level Arena Pharmaceuticals, Inc. (San Diego, CA) ⤷  Try it Free
PSN-375,963 ⤷  Try it Free GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto Arena Pharmaceuticals, Inc. (San Diego, CA) ⤷  Try it Free
PSN-375,963 ⤷  Try it Free Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level Arena Pharmaceuticals, Inc. (San Diego, CA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for PSN-375,963

Drugname Country Document Number Estimated Expiration Related US Patent
PSN-375,963 Australia AU2009258242 2028-05-14 ⤷  Try it Free
PSN-375,963 Australia AU2015213309 2028-05-14 ⤷  Try it Free
PSN-375,963 Brazil BRPI0912545 2028-05-14 ⤷  Try it Free
PSN-375,963 Canada CA2723904 2028-05-14 ⤷  Try it Free
PSN-375,963 China CN102118972 2028-05-14 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Dow
Moodys
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.